Abstract

Although the peroxisome proliferator-activated receptor (PPAR alpha) binds and is activated by a variety of synthetic xenobiotics, the identity of the high affinity endogenous ligand(s) is incompletely resolved. Likewise, it is not known how putative endogenous ligands alter PPAR alpha conformation in order to affect transcriptional regulation. Direct fluorescence binding and fluorescence displacement assays showed for the first time that PPAR alpha exhibits high affinity (1-14 nM K(d) values) for unsaturated long chain fatty acyl-CoAs as well as unsaturated long chain fatty acids commonly found in mammalian cells. Fluorescence resonance energy transfer between PPAR alpha aromatic amino acids and bound corresponding naturally occurring fluorescent ligands (i.e. cis-parinaroyl-CoA, trans-parinaric acid) yielded intermolecular distances of 25-29 angstroms, confirming close molecular interaction. Interestingly, although PPAR alpha also exhibited high affinity for saturated long chain fatty acyl-CoAs, regardless of chain length (1-13 nM K(d) values), saturated long chain fatty acids were not significantly bound. In contrast to the similar affinities of PPAR alpha for fatty acyl-CoAs and unsaturated fatty acids, CoA thioesters of peroxisome proliferator drugs were bound with 5-6-fold higher affinities than their free acid forms. Circular dichroism demonstrated that high affinity ligands (long chain fatty acyl-CoAs, unsaturated fatty acids), but not weak affinity ligands (saturated fatty acids), elicited conformational changes in PPAR alpha structure, a hallmark of ligand-activated nuclear receptors. Finally, these ligand specificities and induced conformational changes correlated functionally with co-activator binding. In summary, since nuclear concentrations of these ligands are in the nanomolar range, long chain fatty acyl-CoAs and unsaturated fatty acids may both represent endogenous PPAR alpha ligands. Furthermore, the finding that saturated fatty acyl-CoAs, rather than saturated fatty acids, are high affinity PPAR alpha ligands provides a mechanism accounting for saturated fatty acid transactivation in cell-based assays.

Highlights

  • The peroxisome proliferator-activated receptor (PPAR␣) binds and is activated by a variety of synthetic xenobiotics, the identity of the high affinity endogenous ligand(s) is incompletely resolved

  • The objective of the present study was to begin to resolve these issues through use of (i) direct ligand binding assays that do not suffer from the limitations of radioligand binding assays, (ii) fluorescence resonance energy transfer (FRET) between Peroxisome proliferator-activated receptors (PPARs)␣ aromatic amino acids and bound fluorescent ligand to calculate the intermolecular distance, (iii) circular dichroism to characterize potential ligandinduced changes in PPAR␣ secondary structure, and (iv) coimmunoprecipitation to determine whether ligands that bind and alter PPAR␣ secondary structure influence the ability of PPAR␣ to interact with co-activators

  • PPAR␣ exhibits high affinity for many xenobiotic peroxisome proliferators and is activated by these agents, identification of endogenous ligands, which are bound with high affinity and conformationally alter PPAR␣, is less clear

Read more

Summary

Introduction

The peroxisome proliferator-activated receptor (PPAR␣) binds and is activated by a variety of synthetic xenobiotics, the identity of the high affinity endogenous ligand(s) is incompletely resolved. More recent data with a direct fluorescent ligand binding assay determined that mouse PPAR␣ binds a naturally occurring fluorescent LCFA, trans-parinaric acid, with high affinity as shown by a Kd of 30 nM [20, 21] Displacement of this fluorescent ligand by nonfluorescent LCFAs yielded nanomolar Ki values for a variety of naturally occurring, nonfluorescent unsaturated LCFAs (arachidonic, linolenic, linoleic, and oleic acids) but not saturated LCFAs (stearic and palmitic acids) [20]. Whether these high affinities reflect a unique property of the fluorescent ligand, trans-parinaric acid, or whether radioligand binding assays underestimate PPAR␣ affinities remains to be determined. These studies would suggest that, especially in the case of saturated LCFAs, a metabolite rather than the saturated LCFA itself might be the active endogenous PPAR␣ ligand [24]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call